Pyrrolo[1,2-B]pyridazine compounds and their uses
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 25, 2006
Grant Date -
Oct 21, 2004
app pub date -
Mar 12, 2004
filing date -
Apr 4, 2003
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Disclosed are novel CRF receptor antagonists and their use as treatment of a variety of disorders, including disorders manifesting hypersecretion of CRF or associated with CRF or CRF receptors, such as anxiety, and depression. CRF receptor antagonists of the invention have the structure of formula (I): ##STR1##
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully